Detalles de la búsqueda
1.
Unveiling the Research Landscape and Emerging Trends in Cell Cycle for Cancer Immunotherapy: A Bibliometric Analysis (1990-2022).
Med Sci Monit;
29: e940556, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38037303
2.
Interaction between baseline HBV loads and the prognosis of patients with HCC receiving anti-PD-1 in combination with antiangiogenic therapy undergoing concurrent TAF prophylaxis.
BMC Infect Dis;
22(1): 614, 2022 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35836207
3.
Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma.
Gastroenterology;
153(1): 249-262.e2, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28363643
4.
[Relationship between CCL20/CCR6/Th17 axis and vascular invasion and metastasis in patients with primary hepatocellular carcinoma].
Zhonghua Zhong Liu Za Zhi;
37(1): 5-10, 2015 Jan.
Artículo
en Zh
| MEDLINE | ID: mdl-25877311
5.
Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial.
PLoS Med;
11(12): e1001774, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25549238
6.
Transarterial chemoembolization with/without immune checkpoint inhibitors plus tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a single center, propensity score matching real-world study.
Discov Oncol;
15(1): 68, 2024 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38460053
7.
A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma.
Signal Transduct Target Ther;
9(1): 101, 2024 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38643203
8.
Tyrosine kinase inhibitors, immune checkpoint inhibitors combined with hepatic arterial infusion of oxaliplatin and raltitrexed versus oxaliplatin, 5-fluorouracil and leucovorin for intermediate and advanced hepatocellular carcinoma: A retrospective study.
Int Immunopharmacol;
125(Pt A): 111019, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37879230
9.
Characterization of somatic mutations and pathway alterations during hepatocellular carcinoma vascular invasion using next-generation sequencing.
J Gastrointest Oncol;
13(4): 1864-1874, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36092348
10.
Hepatic Tumor Stiffness Measured by Shear Wave Elastography Is Prognostic for HCC Progression Following Treatment With Anti-PD-1 Antibodies Plus Lenvatinib: A Retrospective Analysis of Two Independent Cohorts.
Front Immunol;
13: 868809, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35757765
11.
Lenvatinib Plus Camrelizumab vs. Lenvatinib Monotherapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study.
Front Oncol;
12: 809709, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35280760
12.
Interaction between hepatitis B virus infection and the efficacy of camrelizumab in combination with apatinib therapy in patients with hepatocellular carcinoma: a multicenter retrospective cohort study.
Ann Transl Med;
9(18): 1412, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34733964
13.
Safety and Efficacy of Camrelizumab Combined with Apatinib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
Onco Targets Ther;
13: 12683-12693, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33328740
14.
Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients.
Front Immunol;
11: 613946, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33488622
15.
Immunization with glypican-3 nanovaccine containing TLR7 agonist prevents the development of carcinogen-induced precancerous hepatic lesions to cancer in a murine model.
Am J Transl Res;
10(6): 1736-1749, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30018715
16.
IL-23 production of liver inflammatory macrophages to damaged hepatocytes promotes hepatocellular carcinoma development after chronic hepatitis B virus infection.
Biochim Biophys Acta Mol Basis Dis;
1864(12): 3759-3770, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30292634
17.
CCR6+ B lymphocytes responding to tumor cell-derived CCL20 support hepatocellular carcinoma progression via enhancing angiogenesis.
Am J Cancer Res;
7(5): 1151-1163, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28560063
18.
Activation of mucosal mast cells promotes inflammation-related colon cancer development through recruiting and modulating inflammatory CD11b(+)Gr1(+) cells.
Cancer Lett;
364(2): 173-80, 2015 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25986744
19.
Monocyte-derived dendritic cells: targets as potent antigen-presenting cells for the design of vaccines against infectious diseases.
Int J Infect Dis;
19: 1-5, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24216295
20.
Elevated pretherapy serum IL17 in primary hepatocellular carcinoma patients correlate to increased risk of early recurrence after curative hepatectomy.
PLoS One;
7(12): e50035, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23227158
Resultados
1 -
20
de 20
1
Próxima >
>>